Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.

Sexually transmitted diseases·2001
Same author

Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus.

Antiviral research·2001
Same author

In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.

Antiviral research·2000
Same author

Development of keratoacanthomas and squamous cell carcinomas in transgenic rabbits with targeted expression of EJras oncogene in epidermis.

The American journal of pathology·1999
Same author

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Antimicrobial agents and chemotherapy·1999
Same author

Therapeutic evaluation of compounds in the SCID-RA papillomavirus model.

Antiviral research·1998

相关实验视频

Updated: Jul 5, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

鼠类白血病的BCG抑制:局部抑制和全身瘤免疫需要不同的剂量.

G L Bartlett, D M Purnell, J W Kreider

    Science (New York, N.Y.)
    |January 23, 1976
    PubMed
    概括

    最佳的菌卡尔梅特-盖林 (BCG) 和瘤细胞比率用于立即抑制瘤,阻碍了对LSTRA小鼠白血病的长期免疫力的发展. 这表明,有效的癌症免疫疗法需要一个微妙的平衡.

    科学领域:

    • 免疫学 免疫学 免疫学
    • 在瘤学瘤学.
    • 癌症研究 癌症研究

    背景情况:

    • Calmette-Guérin (BCG) 是一种用于治疗某些癌症的免疫疗法剂.
    • BCG和瘤细胞之间的相互作用对于治疗结果至关重要.
    • 了解最佳比率是增强抗瘤免疫力的关键.

    研究的目的:

    • 为了研究BCG和瘤细胞之间的定量关系.
    • 确定这些比率对瘤生长抑制和全身免疫的影响.
    • 在LSTRA小鼠白血病模型中确定促进持续瘤排斥免疫力的条件.

    主要方法:

    • 使用LSTRA小鼠白血病模型.
    • 管理BCG和瘤细胞的不同定量混合物.
    • 监测瘤生长和评估系统性抗瘤免疫的发展.

    主要成果:

    • 特定的BCG-瘤细胞比率被确定为最佳的立即瘤生长抑制.
    • 发现这些最佳比率对持续的,全身性瘤排斥免疫的发展有害.
    • 在急性瘤控制和诱导长期持久的抗白血病免疫力之间存在权衡.

    结论:

    更多相关视频

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
    11:15

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

    Published on: September 1, 2018

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    相关实验视频

    Last Updated: Jul 5, 2026

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
    06:32

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

    Published on: September 19, 2016

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
    11:15

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

    Published on: September 1, 2018

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    • BCG和瘤细胞之间的定量关系显著影响抗瘤免疫的发展.
    • 实现持续的瘤排斥需要谨慎的平衡,因为理想的比例立即抑制可能会损害长期的免疫反应.
    • 需要进一步的研究来优化基于BCG的免疫治疗策略,以持续控制癌症.